| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Revenue | $0.4B | $0.4B | $0.4B |
| Cost of Revenue | — | — | — |
| Gross Profit | — | — | — |
| R&D Expense | — | — | — |
| SG&A Expense | — | — | — |
| Operating Income | $0.1B | $0.1B | $0.1B |
| Net Income | $0.0B | $0.1B | $0.1B |
| EPS (Basic) | $0.73 | $1.32 | $1.37 |
| EPS (Diluted) | $0.72 | $1.31 | $1.37 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Total Assets | $8.5B | $8.0B | $7.6B |
| Current Assets | $0.5B | $0.4B | $0.4B |
| Cash & Equivalents | $0.0B | $0.0B | $0.0B |
| Total Liabilities | $5.6B | $5.1B | $4.8B |
| Current Liabilities | $0.7B | $0.8B | $0.5B |
| Stockholders' Equity | $2.9B | $2.9B | $2.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Operating Cash Flow | $0.4B | $0.4B | $0.5B |
| Investing Cash Flow | $-0.6B | $-0.6B | $-0.6B |
| Capital Expenditures | $0.5B | $0.5B | $0.6B |
| Financing Cash Flow | $0.2B | $0.2B | $0.1B |